| Financial Year |
March 31 2023 |
| Monetary Funds |
80,889,374.19 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
233,744,651.62 |
| Accounts Receivable |
362,824,054.89 |
| Advances to Suppliers |
85,135,257.65 |
| Other Receivables |
75,171,954.83 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
287,199,048.24 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
76,359,383.36 |
| Other Current Assets |
9,933,444.08 |
| Total Current Assets |
1,244,059,300.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
250,026,936.16 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,504,421,536.32 |
| Under-construction Projects |
280,125,772.19 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
549,978,931.27 |
| R&D expenses |
4,943,723.62 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,826,590.33 |
| Deferred Income Tax Assets |
9,056,613.44 |
| Other Non-Current Assets |
81,997,288.39 |
| Sub-Total of Non-Current Assets |
2,690,776,808.80 |
| Total Assets |
3,934,836,109.32 |
| Short-Term Loans |
123,749,170.64 |
| Trading Financial liabilities |
-- |
| Notes Payable |
84,757,283.83 |
| Accounts Payable |
660,482,136.75 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
41,907,737.82 |
| Taxes Payable |
18,186,590.72 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
104,482,109.18 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
152,289,459.24 |
| Other Current Liabilities |
304,894,335.83 |
| Sub-Total of Current Liabilities |
1,514,214,289.39 |
| Long-term Loans |
100,712,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,114,749.91 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
272,210,254.65 |
| Total Liabilities |
1,786,424,544.04 |
| Paid-In Capital(Or Share Stock) |
675,604,211.00 |
| Capital Surplus |
1,110,367,828.91 |
| Surplus Reserve |
290,341,229.76 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,830,691.80 |
| Minority Stockholder's Interest |
68,267,603.81 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,080,143,961.47 |
| Owner's Equity（Stockholder's Equity） |
2,148,411,565.28 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,934,836,109.32 |
